Not Every Breast Cancer Study Is a Clinical Trial

"Research study" covers a wide range of projects, and knowing which kind you have been invited to shapes what you need to ask.

Treatment trials test new drugs, combinations, surgical approaches, or radiation schedules, and they usually involve medical procedures, regular visits, and close monitoring. Prevention and screening studies look at ways to lower risk or find cancer earlier. Supportive care studies focus on quality of life, such as managing fatigue, pain, or anxiety during and after treatment.

Other studies involve no treatment at all. In an interview or focus group study, a researcher asks you to talk about your experience, perhaps of diagnosis, treatment decisions, survivorship, or caring for someone with breast cancer, and the conversation is usually recorded. Survey studies ask you to fill in questionnaires, sometimes more than once over months or years. Registries and biobanks collect health information or samples to support future research.

Each of these carries different demands and different risks. A treatment trial raises questions about side effects and how it fits with your current care, while an interview study raises questions about emotional strain and what happens to your recorded words.

Consent Is a Conversation, Not a Signature

Informed consent is often thought of as a form you sign at the start, but it works better as an ongoing conversation. A good research team explains the study in plain language, gives you time to read the consent form at home if you want it, and answers your questions before, during, and after you take part. You can usually bring a family member or friend to that conversation, and you can ask for anything you do not understand to be explained again.

Under the federal rules that govern most research in the United States, consent forms must tell you that participation is voluntary and that you may stop at any time without penalty or loss of benefits you are otherwise entitled to. In practice, that means stepping away from a study should not change the standard care you receive from your doctors.

Most studies are also reviewed by an ethics committee, usually called an Institutional Review Board or IRB, before they can begin. The IRB's job is to protect participants, and the consent form should include contact details you can use if you have concerns about how the study is being run.

Questions Worth Asking

The National Cancer Institute suggests asking about the study's purpose, its risks and benefits, your rights, its costs, and how it would affect your daily life. The questions below follow that approach, with extra attention to privacy for studies that record what you say.

About the study itself

Who is running the study, and who is paying for it? What is it trying to learn? How much time will it take, both per visit or interview and over the full length of the study? Would you need to travel, and is there help with travel costs or compensation for your time? Will you hear about the results when the study ends?

About risks and benefits

What are the possible physical or emotional risks, and how often do they happen? Is there any chance of direct benefit to you, or is the study mainly meant to help future patients? If a conversation or procedure becomes difficult, what support is available? For treatment trials, how does the study compare with your standard treatment options, and what would happen to your care if you left partway through? Some of these questions are best asked of your own oncologist as well as the research team.

About your privacy and recordings

Will your interview or focus group be recorded, as sound only or on video, and can you ask for the recording to be paused? Who will listen to the recording or read the transcript, and have they signed confidentiality agreements? Will your name and identifying details, such as your hospital, town, or employer, be removed from transcripts and notes? Where will recordings and data be stored, and how long will they be kept before deletion? If the researchers quote you in a report or publication, will they use a pseudonym, and could anything in the quote still identify you?

It also helps to know two protections that may apply. If the study uses health information from your medical records, you will usually be asked to sign a HIPAA authorization, which you can later revoke in writing, although information already collected may still be used to protect the integrity of the study. Research funded by the National Institutes of Health that collects identifiable, sensitive information is automatically covered by a Certificate of Confidentiality, which generally prevents the researchers from being forced to hand over your identifying information in response to legal demands such as a subpoena, and studies with other funding can apply for one. The explainer on de-identification, anonymization, and pseudonymization describes the different ways researchers remove identifying details, which can help you make sense of what a consent form promises.

About oversight and your right to stop

Has the study been approved by an IRB or ethics committee? Who can you contact if you have a concern and would rather not raise it with the research team directly? If you withdraw, what happens to the information or recordings you have already provided, and can you ask for them to be removed?

Red Flags Worth Noticing

Most research teams are careful and respectful, but a few signs suggest you should slow down or ask more questions. Be cautious if you feel pressure to sign the same day without time to read the consent form, or if someone suggests your regular care might suffer if you decline. Vague answers about who will hear your recordings, where your data will be stored, or how long it will be kept are also worth questioning. So is any request to pay to join a study, any promise that a study will cure you, or a consent form that does not name an ethics review board or a contact for concerns.

If something feels wrong, you can contact the IRB listed on the consent form, ask your own doctor for a second opinion, or simply decline.

Where to Find Studies You Can Trust

If you are looking for studies yourself rather than responding to an invitation, start with established sources. ClinicalTrials.gov is the U.S. government's registry of clinical studies and lists trials at sites around the world. The National Cancer Institute offers a clinical trial search and a contact center at 1-800-4-CANCER (1-800-422-6237), where trained specialists can help you understand your options.

Susan G. Komen's Breast Cancer Helpline, at 1-877-GO-KOMEN (1-877-465-6636), connects callers with navigators who can help them understand clinical trials, and the service is available in Spanish. Your own cancer center is also a good place to ask, since many run their own studies and have research nurses or coordinators who can answer these questions.

A Checklist to Bring to the Conversation

Screenshot or print this and take it with you when you talk to the research team.

• What kind of study is this, and what would I be asked to do?

• How much time will it take, and will it cost me anything?

• What are the risks, and what support is available if it becomes difficult?

• Who will hear or read what I share, and how will my identity be protected?

• Who reviewed this study, and how do I stop if I change my mind?

People who take part in breast cancer research, whether by trying a new treatment or by sitting down to describe what the past year has been like, shape the care that others receive after them. That contribution matters, and so does protecting your own time, health, and privacy. Whatever you decide after asking your questions is the right decision for you.

Frequently Asked Questions

Will joining a study affect my treatment? A treatment trial will change the treatment you receive while you are in it, which is why it is worth discussing with your own oncologist. Interview, focus group, and survey studies do not involve any change to your treatment. For research covered by federal rules, declining or withdrawing should not affect the standard care you are otherwise entitled to.

Can I change my mind after an interview? Yes. You can stop at any point, including partway through an interview. Ask the research team what will happen to anything you have already shared, since some studies can remove your data and others may have already de-identified and combined it.

Will anyone know I took part? That depends on the study's privacy protections, which the consent form should explain. Most studies replace names with codes or pseudonyms in transcripts and publications, limit who can access identifiable information, and store data securely. Ask specifically who will hear your recording and whether quotes could identify you.

Do I have to answer every question in an interview? No. You can skip any question, ask for the recording to be paused, or end the interview at any time.

Is there a cost to join a breast cancer study? Interview and survey studies usually cost nothing, and some offer compensation for your time. Treatment trials vary, so ask which costs the study covers and which would go to your insurance. Be cautious of any study that asks you to pay to take part.